If you liked this article you might like

EpiPen Competitor Auvi-Q Will Return in February, but It'll Cost Insurance Companies Big Bucks
Eli Lilly and Express Scripts Announce Program to Lower Insulin Prices to Avoid Mylan-Like Uproar
Kaleo CEO Positive on EpiPen Competition
Mylan Falls on News of the Return of Auvi-Q